Long-term outcome of presymptomatic testing in Huntington disease

European Journal of Human Genetics

Volumn 17, Issue 2, 2009, Pages 165-171

  Gargiulo, Marcela ^a   Lejeune, Séverine ^a   Tanguy, Marie Laure ^a   Lahlou Laforêt, Khadija ^b   Faudet, Anne ^a   Cohen, David ^a   Feingold, Josué ^a   Durr, Alexandra ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; MINI INTERNATIONAL NEUROPSYCHIATRIC INVENTORY; MUTATIONAL ANALYSIS; PREDICTION; PRIORITY JOURNAL; SELF REPORT; SOCIAL ADAPTATION; SOCIAL DISABILITY; STRUCTURED INTERVIEW; SYMPTOMATOLOGY;

DEPRESSION; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HUNTINGTON DISEASE; INTERVIEWS AS TOPIC; MULTIVARIATE ANALYSIS;

EID: 58349089223     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.146     Document Type: Article

References (27)

1. Guidelines for the molecular genetics predictive test in Huntington's disease: International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology 1994; 4: 1533-1536.
2. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR: A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999; 64: 1293-1304.
3. Evers-Kiebooms G, Decruyenaere M: Predictive testing for Huntington's disease: A challenge for persons at risk and for professionals. Patient Educ Couns 1998; 35: 15-26.
4. Goizet C, Lesca G, Duff A: Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 2002; 59: 1330-1336.
5. Mandich P, Jacopini G, Di Maria E et al: Predictive testing for Huntington's disease: Ten years' experience in two Italian centres. Ital J Neurol Sci 1998; 19: 68-74.
6. Decruyehaere M, Evers-Kiebooms G, Boogaerts A et al: Predictive testing for Huntington's disease: Risk perception, reasons for testing and psychological profile of test applicants. Genet Couns 1995; 6: 1-13.
7. Decruyenaere M, Evers-Kiebooms G, Boogaerts A et al: Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. J Med Genet 1996; 33: 737-743.
8. Decruyenaere M, Evers-Kiebooms G, Cloostermans et al: Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet 2003; 11: 30-38.
9. Duisterhof M, Trijsburg RW, Niermeijer MF, Roos RA, Tibben A: Psychological studies in Huntington's disease: Making up the balance. J Med Genet 2001; 38: 852-861.
10. Tibben A, Duivenvoorden HJ, Niermeijer MF, Vegter-van der Vlis M, Roos RA, Verhage F: Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom Med 1994; 56: 526-532.
11. Timman R, Roos R, Maat-Kievit A, Tibben A: Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7-10 years after the test. Health Psychol 2004; 23: 189-197.
12. Wiggins S, Whyte P, Huggins M et al: The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med 1992; 327: 1401-1405.
13. Almqvist EW, Brinkman RR, Wiggins S, Hayden MR: Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin Genet 2003; 64: 300-309.
14. Dode C, Durr A, Pecheux C et al: Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis. C R Acad Sci III 1993; 316: 1374-1380.
15. Amiel-Lebigre F: [Existential events and psychopathology]. Encephale 1983; 9: 9B-16B.
16. Lazarus R: Emotion and Adaptation. New York: Oxford University Press, 1991.
17. Collet L, Cottraux J: [The shortened Beck depression inventory (13 items). Study of the concurrent validity with the Hamilton scale and Widlocher's retardation scale]. Encephale 1986; 12: 77-79.
18. Sheehan DV, Lecrubier Y, Sheehan KH et al: The Mini-International Neuropsychiatric Interview (M I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33; quiz 34-57.
19. Beck AT, Steer RA, Kovacs M, Garrison B: Hopelessness and eventual suicide: A 10-year prospective study of patients hospitalized with suicidal ideation.Am J Psychiatry 1985; 142: 559-563.
20. Hodgues WF, Spielberger CD: An indicant of trait or state anxiety? J Consult Clin Psychol 1969; 33: 430-434.
21. Horowitz M, WilneA N, Alvarez W: Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218.
22. Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK: Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978; 166: 317-326.
23. Julien CL, Thompson JC, Wild S et al: Psychiatric disorders in preclinical Huntington's disease. J Nourol Neurosurg Psychiatry 2007; 78: 939-943.
24. Demyttenaere K, Bruffaerts R, Posada-Villa J et al: Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291 2581-2590.
25. Lepine JP, Gasquet I, Kovess V et al: [Prevalence and comorbidity of psychiatric disorders in the French general population]. Encephale 2005; 31: 182-194.
26. Robins Wahlin TB, Backman L, Lundin A, Haegermark A, Winblad B, Anvret M: High suicidal ideation in persons testing for Huntington's disease. Acta Neurol Scand 2000; 102: 150-161.
27. Tibben A, Timman R, Bannink EC, Duivenvoorden HJ: Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 1997; 16: 20-35.